Favorable therapeutic index of a p210BCR-ABL-specific tyrosine kinase inhibitor; activity on lineage-committed and primitive chronic myelogenous leukemia progenitors

✍ Scribed by Bernd Kasper; Stefan Fruehauf; Bernd Schiedlmeier; Elisabeth Buchdunger; Anthony D. Ho; W. Jens Zeller

• Book ID: 105994560
• Publisher: Springer
• Year: 1999
• Tongue: English
• Weight: 170 KB
• Volume: 44
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s002800051001